Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Meibach, R."'
Autor:
LaRocca, NG, Hudson, LD, Rudick, R, Amtmann, D, Balcer, L, Benedict, R, Bermel, R, Chang, I, Chiaravalloti, ND, Chin, P, Cohen, JA, Cutter, GR, Davis, MD, DeLuca, J, Feys, P, Francis, G, Goldman, MD, Hartley, E, Kapoor, R, Lublin, F, Lundstrom, G, Matthews, PM, Mayo, N, Meibach, R, Miller, DM, Motl, RW, Mowry, EM, Naismith, R, Neville, J, Panagoulias, J, Panzara, M, Phillips, G, Robbins, A, Sidovar, MF, Smith, KE, Sperling, B, Uitdehaag, BM, Weaver, J, Multiple Sclerosis Outcome Assessments Consortium (MSOAC)
Publikováno v:
Multiple Sclerosis Journal, 24(11), 1469-1484. SAGE Publications Ltd
Multiple Sclerosis (Houndmills, Basingstoke, England)
Multiple Sclerosis Outcome Assessments Consortium (MSOAC) 2018, ' The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability ', Multiple Sclerosis Journal, vol. 24, no. 11, pp. 1469-1484 . https://doi.org/10.1177/1352458517723718
Multiple Sclerosis (Houndmills, Basingstoke, England)
Multiple Sclerosis Outcome Assessments Consortium (MSOAC) 2018, ' The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability ', Multiple Sclerosis Journal, vol. 24, no. 11, pp. 1469-1484 . https://doi.org/10.1177/1352458517723718
Background: The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) was formed by the National MS Society to develop improved measures of multiple sclerosis (MS)-related disability. Objectives: (1) To assess the current literature and available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0a745dfe2c0510c571629e202d3b03
https://research.vumc.nl/en/publications/fb260b55-8245-4745-81e8-76c5dc4e2019
https://research.vumc.nl/en/publications/fb260b55-8245-4745-81e8-76c5dc4e2019
Autor:
Vanderstichele, H., Stephenson, D., Shaw, L.M., Carrillo, M., Umek, R., Rajapakse, H., Luthman, J., Soares, H., Gordon, M.F., Devanarayan, V., Genius, J., Berman, R., Hendrix, J., Romero, K., Kaplow, J., Willis, B., Hitchcock, J., Yu, P., Lawson, J., Raunig, D., Meibach, R., Ito, K., Beckett, L., Engelborghs, Sebastiaan, Blennow, K., Dean, R.A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::190131d1ca684b432870c96703b7bd30
https://biblio.vub.ac.be/vubir/the-path-to-regulatory-qualification-of-cerebrospinal-fluid-biomarkers-as-enrichment-tools-in-clinical-trials-of-patients-with-early-alzheimers-disease-for-the-coalition-against-major-diseases(8465d8a8-100e-42d3-b771-d515b7f41825).html
https://biblio.vub.ac.be/vubir/the-path-to-regulatory-qualification-of-cerebrospinal-fluid-biomarkers-as-enrichment-tools-in-clinical-trials-of-patients-with-early-alzheimers-disease-for-the-coalition-against-major-diseases(8465d8a8-100e-42d3-b771-d515b7f41825).html
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
Autor:
Feinklestein, SP, Fisher, M, Furland, AJ, Goldstein, LB, Gorelick, PB, Kaste, M, Lees, KR, Traystman, RJ, Albers, GW, Anwer, UE, Ashwood, T, Barone, FC, Basta, SL, Bogousslavsky, J, Buchan, AM, Cady, WJ, Chan, PH, Clemens, JA, Cox, BF, Craddock, RE, Cramer, SC, del Zoppo, GJ, Dielrich, WD, Elliott, P, Faden, AI, Feuerstein, GZ, Ginsberg, MD, Gold, M, Greene, WL, Hall, ED, Hsu, CY, Hunter, AJ, Lai, M, Lesko, LM, Levy, DE, Li, FH, Locke, KW, Lodge, D, Lowe, D, Marcoux, FW, McCulloch, J, McDermott, J, Meibach, R, Messersmith, EK, Moseley, M, Moskowitz, MA, Mueller, AL, Munro, F, Nudo, RJ, Oeda, J, Ohlstein, EH, Parsons, A, Patmore, L, Poole, RM, Pschorn, U, Pulsinelli, WA, Sacco, RL, Saeki, S, Salazar-Grueso, E, Sandage, BW, Schallert, T, Schielke, GP, Sharkey, J, Sotak, CH, Steiger, B, Storall, S, Takahashi, Y, Tumas, D, Van Bruggen, N, Versavel, M, Vornov, J, Walker, MD, Wallin, B, Wang, J, Warach, S, Wells, DS, Witcher, JA, Round, STAI
Publikováno v:
Europe PubMed Central
Abstract —The plethora of failed clinical trials with neuroprotective drugs for acute ischemic stroke have raised justifiable concerns about how best to proceed for the future development of such interventions. Preclinical testing of neuroprotectiv
Autor:
Hill, D., Beckett, L., Boccardi, M., Brumfield, M., Budd, D., Burns, L., Carillo, M., Cole, P.E., Dean, R., Engelborghs, Sebastiaan, Fox, N., Frisoni, G., Gordon, M., Hartley, D., Hayes, W., Hitchcock, J., Hudson, L., Isaac, M., Jack, C., Jeromin, A., Kelleher, T., Lu, F., Maguire, P., Meibach, R., Novak, G., Patterson, P., Romano, G., Schwarz, A., Shaw, L., Simon, A.J., Raunig, D., Soares, H., Suhy, J., Thies, W., Vanderstichele, H., Yu, P., Wang, H., Walton, M., Stephenson, D.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::5872a5af721fc283826370b577003e3e
https://biblio.vub.ac.be/vubir/coalition-against-major-diseases-advancement-of-csf-and-neuroimaging-biomarkers-as-drug-development-tools-to-enable-clinical-trials-in-mci(ac6e9983-d2f0-4665-9b0e-699d2bd95f98).html
https://biblio.vub.ac.be/vubir/coalition-against-major-diseases-advancement-of-csf-and-neuroimaging-biomarkers-as-drug-development-tools-to-enable-clinical-trials-in-mci(ac6e9983-d2f0-4665-9b0e-699d2bd95f98).html
Autor:
Snoeck, E., Peer, A., Mannens, G., Woestenborghs, R., Heykants, J., Sack, M., Horton, M., Meibach, R.
Publikováno v:
Psychopharmacology; 1995, Vol. 122 Issue 3, p223-229, 7p
Autor:
Meibach, R., Weaver, Linda
Publikováno v:
Journal of Neural Transmission; 1979, Vol. 44 Issue 1/2, p87-96, 10p
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; March 1981, Vol. 78 Issue: 3 p1958-1961, 4p
Autor:
Meibach, R C
Publikováno v:
Journal of Histochemistry and Cytochemistry; August 1982, Vol. 30 Issue: 8 p831-836, 6p
Autor:
van der Klauw, M. M., Stricker, B. H. Ch., Ottervanger, J. P., van der Meché, F. G. A., van Griensven, J. M. T., Lemkes, H. H. P. J., Kroon, J. M., Schoemaker, H. C., Cohen, A. F., Schellens, J. H. M., Loos, W., van Acker, B., de Boer-Dennert, M., Planting, A. S. T., van der Burg, M. E. L., Stoter, G., Krediet, R., Verweij, J., Blaak, E. E., van Baak, M. A., Kemerink, G. J., Pakbiers, M. T. W., Heidendal, G. A. K., Saris, W. H. M., Bouckaert, S., Vakaet, L., Dhont, M., Remon, J. P., van den Broek, S. A. J., de Graeff, P. A., van Gilst, W. H., van Veldhuisen, D. J., Hillige, H. L., Wesseling, H., Lie, K. I., Gaillard, C. A., van Es, P. N., de Leeuw, P. W., Van Bortel, L. M. A. B., Kool, M. J. F., Lustermans, F. A. T., Breed, J. G. S., Hoeks, A. P. G., Boudier, H. A. J. Struijker, Pickkers, R. P., Smits, P., Baadenhuysen, H., van 't Laar, A., Thien, Th., Elseviers, M. M., De Broe, M. E., van der Ven, A. J. A. M., Koopmans, P. P., Peters, W. H. M., Vree, T. B., van der Meer, J. W. M., Snoeck, E., Van Peer, A., Sack, M., Horton, M., Mannens, G., Woestenborghs, R., Heykants, J., Meibach, R., van Witsen, T. B., Valkenburg, H. A., Vander Stichele, R. H., De Potter, B., Vyncke, P., Bogaert, M. G., Burggraaf, J., Wollersheim, H., van Aalen, J., Schoemaker, R. G., Du, X. Y., Bax, W. A., Bos, E., Saxena, P. R., Rongen, G. A., van Heiningen, P. N. M., Schwietert, H. R., Kortboyer, J. M., Sollie, F. A. E., Piraube, C., Desché, P., Jonkman, J. H. G., Blok, W. L., Gyssens, I. C., Hekster, Y. A., Koopmans, P. P., van der Meer, J. W. M., Jansen, P. A. F., Sival, R. C., van Nieuwkerk, J. F., Klaverwiiden, B., de Bruijn, E. A., Driessen, O.
Publikováno v:
Pharmacy World & Science; June 1993, Vol. 15 Issue: Supplement 5 p1-7, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.